Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc. (RAPH) shows zero cyber incidents and zero red-flag 8-K filings in our 90-day monitoring window, indicating no immediate governance disruptions or disclosure events. However, a clean recent window does not eliminate underlying risk—our analysis extends across 12 months of filings, financing history, and dilution metrics that may not yet be visible in short-term data. The full $49 Report adds a dilution risk score, detailed 8-K context, capital structure analysis, and AI-flagged risk signals that reveal structural vulnerabilities in the equity and balance sheet. This deeper view provides the context needed to assess whether Raphael's quiet period reflects genuine stability or masked financial strain.